RxDoctor Payments Data

Ashley Fultz, APRN

Family · Middlesboro, KYNPI 1457694960

Payments from drug & device makers

$3,184in general payments, 2019–2025

Across 199 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$742
  • AbbVie$617
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$277
  • Pfizer$203
  • Exact Sciences$115
  • Xeris Pharmaceuticals, Inc.$107
  • plus $1K from 26 others

What the payments were for

  • Food & beverage$3,184100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,184 in reported general payments places this provider in the 85th percentile of 4,374 family providers in Kentucky.

See all family providers in Kentucky

Medicare billing

Part B allowed, 2024
$114,390
Medicare patients
296
Services billed
9,549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban128$124,213
JardianceEmpagliflozin98$110,866
MounjaroTirzepatide91$101,081
OzempicSemaglutide77$76,605
TrulicityDulaglutide48$61,462
Tresiba Flextouch U-200Insulin Degludec51$50,877
JanuviaSitagliptin Phosphate36$39,462
VraylarCariprazine Hcl25$36,042
Trelegy ElliptaFluticasone/Umeclidin/Vilanter38$33,762
RybelsusSemaglutide22$32,970
TradjentaLinagliptin32$31,237
LinzessLinaclotide29$20,967
XareltoRivaroxaban13$20,233
Breztri AerosphereBudesonide/Glycopyr/Formoterol21$19,319
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen683$17,281

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$59$162,542139 claims
Boehringer IngelheimJardiance, Tradjenta, Glyxambi$61$150,729143 claims
PfizerEliquis, Premarin$203$128,888143 claims
Novo NordiskOzempic, Rybelsus$742$109,57599 claims
AbbVieVraylar, Linzess$617$57,00954 claims
GSKTrelegy Ellipta, Anoro Ellipta$29$43,64651 claims
AstraZenecaBreztri Aerosphere, Farxiga, Symbicort, Nexium$72$42,45074 claims
MerckJanuvia$17$39,46236 claims
Johnson & JohnsonXarelto$38$20,23313 claims
Sumitomo Pharma America, Inc.Gemtesa$58$8,85411 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,374 family providers in Kentucky.

Other family in Middlesboro

See the full list for Kentucky

Where these figures come from

Is this you, or does something look wrong? →